Robert Glanzman - Net Worth and Insider Trading

Robert Glanzman Net Worth

The estimated net worth of Robert Glanzman is at least $2,191 dollars as of 2024-11-29. Robert Glanzman is the Chief Medical Officer of Clene Inc and owns about 528 shares of Clene Inc (CLNN) stock worth over $2,191. Details can be seen in Robert Glanzman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Glanzman has not made any transactions after 2022-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Robert Glanzman

Robert Glanzman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Glanzman owns 1 companies in total, including Clene Inc (CLNN) .

Click here to see the complete history of Robert Glanzman’s form 4 insider trades.

Insider Ownership Summary of Robert Glanzman

Ticker	Comapny	Transaction Date	Type of Owner
CLNN	Clene Inc	2022-05-16	Chief Medical Officer

Robert Glanzman Latest Holdings Summary

Robert Glanzman currently owns a total of 1 stock. Robert Glanzman owns 528 shares of Clene Inc (CLNN) as of May 16, 2022, with a value of $2,191.

Latest Holdings of Robert Glanzman

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
CLNN	Clene Inc	2022-05-16	528	4.15	2,191

Holding Weightings of Robert Glanzman

Robert Glanzman Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Glanzman has made a total of 1 transactions in Clene Inc (CLNN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Clene Inc is the sale of 236 shares on May 16, 2022, which brought Robert Glanzman around $9,576.

Insider Trading History of Robert Glanzman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Glanzman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert Glanzman Ownership Network

Ownership Network List of Robert Glanzman

No Data

Ownership Network Relation of Robert Glanzman

Robert Glanzman Owned Company Details

What does Clene Inc do?

Who are the key executives at Clene Inc?

Robert Glanzman is the Chief Medical Officer of Clene Inc. Other key executives at Clene Inc include director & Chief Executive Officer Robert Dee Etherington , Chief Science Officer Mark Mortenson , and 10 percent owner General Resonance Llc .

Clene Inc (CLNN) Insider Trades Summary

Over the past 18 months, Robert Glanzman made no insider transaction in Clene Inc (CLNN). Other recent insider transactions involving Clene Inc (CLNN) include a net purchase of 1,842,309 shares made by David J Matlin , a net sale of 58,500 shares made by General Resonance Llc , and a net purchase of 35,000 shares made by Robert Dee Etherington .

In summary, during the past 3 months, insiders sold 0 shares of Clene Inc (CLNN) in total and bought 122,819 shares, with a net purchase of 122,819 shares. During the past 18 months, 2,925 shares of Clene Inc (CLNN) were sold and 722,111 shares were bought by its insiders, resulting in a net purchase of 719,186 shares.

Clene Inc (CLNN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Clene Inc Insider Transactions

No Available Data

Robert Glanzman Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Glanzman. You might contact Robert Glanzman via mailing address: 6550 South Millrock Drive, Suite G50, Salt Lake City Ut 84121.

Discussions on Robert Glanzman

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.